Michiel Costers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michiel Costers has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Carine Wouters
Division of Pediatric Rheumatology, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium
1 shared publication Elena Levtchenko
Department of Pediatric Nephrology, University Hospital Leuven Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
1 shared publicationGuy Bogaert
Department of Pediatric Urology, University Hospital Leuven Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
1 shared publicationJan Verhaegen
Department of Laboratory Medicine (Microbiology), University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium
1 shared publicationPierre Moens
Department of Orthopaedic Surgery, University Hospital Leuven, Leuven, Belgium
1 shared publicationRita Van Damme-Lombaerts
Department of Pediatric Nephrology and Organ Transplantation, University Hospital Leuven Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
1 shared publication
Latest Publications
- Open Access
- 29 July 2008
- Published by Hindawi Limited in Advances in Urology
- Vol. 2008, 1-5
Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today?
The main goal of the management of vesicoureteral reflux (VUR) is prevention of recurrent urinary tract infections (UTIs), and thereby prevention of renal parenchymal damage possibly ensuing from these infections. Long-term antibiotic prophylaxis is common practice in the management of children with VUR, as recommended in 1997 in the guidelines of the American Urological Association. We performed a systematic review to ascertain whether antibiotics can be safely discontinued in children with VUR and whether prophylaxis is effective in the prevention of recurrent UTIs and renal damage in these patients. Several uncontrolled studies indicate that antibiotic prophylaxis can be discontinued in a subset of patients, that is, school-aged children with low-grade VUR, normal voiding patterns, kidneys without hydronephrosis or scars, and normal anatomy of the urogenital system. Furthermore, a few recent randomized controlled trials suggest that antibiotic prophylaxis offers no advantage over intermittent antibiotic therapy of UTIs in terms of prevention of recurrent UTIs or new renal damage.
- 29 July 2008
- Published by Hindawi Limited in Advances in Urology
- Vol. 2008, 1-5
Open AccessAntibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today?
The main goal of the management of vesicoureteral reflux (VUR) is prevention of recurrent urinary tract infections (UTIs), and thereby prevention of renal parenchymal damage possibly ensuing from these infections. Long-term antibiotic prophylaxis is common practice in the management of children with VUR, as recommended in 1997 in the guidelines of the American Urological Association. We performed a systematic review to ascertain whether antibiotics can be safely discontinued in children with VUR and whether prophylaxis is effective in the prevention of recurrent UTIs and renal damage in these patients. Several uncontrolled studies indicate that antibiotic prophylaxis can be discontinued in a subset of patients, that is, school-aged children with low-grade VUR, normal voiding patterns, kidneys without hydronephrosis or scars, and normal anatomy of the urogenital system. Furthermore, a few recent randomized controlled trials suggest that antibiotic prophylaxis offers no advantage over intermittent antibiotic therapy of UTIs in terms of prevention of recurrent UTIs or new renal damage.
- 9 May 2003
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 162 (7-8) , 530-531
Three cases of Kingella kingae infection in young children
- 9 May 2003
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 162 (7-8) , 530-531
Three cases of Kingella kingae infection in young children